Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients

NCT02499367 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Nivolumab
RADIATION: Radiation therapy
DRUG: Low dose doxorubicin
DRUG: Cyclophosphamide
DRUG: Cisplatin

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]